Mechanisms and Management of Ventricular Tachycardia in STEMI Patients

Primary Mechanisms of VT in STEMI

Ongoing myocardial ischemia is a major trigger for ventricular arrhythmias, with VT/VF often being the first manifestation of ischemia requiring immediate correction 1, 2
Hemodynamic compromise, including pump failure and cardiogenic shock, creates an arrhythmogenic substrate that can trigger VT 2, 3
Electrolyte disturbances, particularly hypomagnesemia and hypokalemia, significantly contribute to the development of VF and should be promptly corrected 1, 2
Autonomic imbalance during acute ischemia alters cardiac electrical properties and can precipitate ventricular arrhythmias 1
Reentry circuits form in damaged myocardium, particularly at the border zones between infarcted and healthy tissue, creating a substrate for VT 4, 5
Enhanced automaticity in surviving myocytes within and surrounding the infarct zone can trigger ventricular arrhythmias 1, 5
Acid-base disturbances associated with acute ischemia can destabilize myocardial cell membranes and promote arrhythmogenesis 1

Early VT/VF (within 48 hours of STEMI onset) occurs in approximately 5-6% of patients undergoing primary PCI, with 60-64% occurring within the first 24 hours 6, 7

Left ventricular aneurysm formation creates a substrate for reentrant VT circuits, particularly in anterior infarctions 4, 5
Papillary muscle dysfunction or rupture can lead to hemodynamic deterioration and trigger arrhythmias 1
Ventricular free wall rupture can present with VT/VF as part of the clinical deterioration 5

Beta-blockers reduce VT/VF incidence in STEMI and should be administered early unless contraindicated 1, 3
Arrhythmia monitoring should be initiated immediately on presentation with STEMI and continued for at least 12-24 hours after reperfusion 6, 7
ICD implantation is indicated before discharge in patients who develop sustained VT/VF more than 48 hours after STEMI, provided the arrhythmia is not due to transient or reversible causes 4, 5

The mechanisms of arrhythmias during acute ischemia differ from those in chronic stable ischemic heart disease, requiring different management approaches 1, 2
Prophylactic lidocaine may reduce VF incidence but has been abandoned due to increased mortality from bradycardia and asystole 1

The European Society of Cardiology recommends considering the anatomical mechanisms of inferior STEMI, including the involvement of the right coronary artery and its impact on the conduction system, in the management of rhythm disturbances 8

The European Heart Journal suggests that immediate recognition of right ventricular involvement through lead V4R is crucial in inferior STEMI, and that continuous cardiac monitoring should begin immediately and continue for at least 12-24 hours after reperfusion 8, 9
The European Heart Journal recommends avoiding vasodilators in right ventricular infarction with bradycardia, as they can reduce preload, and instead maintaining preload with IV fluid loading 8
The European Heart Journal advises against the use of prophylactic antiarrhythmic drugs, including lidocaine, which can increase mortality from bradycardia and asystole despite reducing VF incidence 10
The European Heart Journal suggests that if atrial fibrillation develops in right ventricular infarction, sinus rhythm should be restored promptly, as atrial contribution to right ventricular filling is critical 8
The European Heart Journal recommends using dual-chamber pacing to maintain AV synchrony if heart block develops in right ventricular infarction 8